Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Study Comparing the Frequency of Treatment-Emergent Sexual Dysfunction Over 8 Weeks in Patients With Major Depressive Disorder Treated With Either Duloxetine Hydrochloride or a Selective Serotonin Reuptake Inhibitor Antidepressant and Evaluated Over 6 Months

NCT00561509 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00561509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00561509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Study Comparing the Frequency of Treatment-Emergent Sexual Dysfunction Over 8 Weeks in Patients With Major Depressive Disorder Treated With Either Duloxetine Hydrochloride or a Selective Serotonin Reuptake Inhibitor Antidepressant and Evaluated Over 6 Months
Lead sponsor
Eli Lilly and Company
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
June 30, 2009
Enrollment
1,626 (actual)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder